By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Theratechnologies Inc. 

2310 Alfred-Nobel Boulevard

Saint-Laurent  Quebec  H4S 2A4  Canada
Phone: 514-336-7800 Fax: 514-336-7242


SEARCH JOBS


Industry
Biotechnology






Company News
Health Canada Approves EGRIFTA™ (Tesamorelin For Injection) And Theratechnologies Inc. (TH.TO) Regains Canadian Commercialization Rights To EGRIFTA™ 4/30/2014 11:36:05 AM
Theratechnologies Inc. (TH.TO) To Announce Financial Results For Fiscal Year 2013 2/26/2014 12:40:14 PM
Theratechnologies Inc. (TH.TO) Suspends Most Long-Term R&D Activities, Cuts Jobs 10/30/2012 6:45:19 AM
Theratechnologies Inc. (TH.TO) CEO Exits Role as Company Tightens Third-Quarter Loss 10/12/2012 7:14:51 AM
Theratechnologies Inc. (TH.TO) Cuts 60% of Workforce, Refocus for 2013 12/7/2011 8:08:26 AM
Theratechnologies Inc. (TH.TO) President and CEO to Ring The NASDAQ Stock Market Opening Bell 6/15/2011 10:10:29 AM
Theratechnologies Inc. (TH.TO) Adopts New R&D Business Model to Strengthen Its Growth Potential; Cuts 24 Jobs 6/2/2011 12:48:42 PM
Theratechnologies Inc. (TH.TO) Announces a Distribution and Licensing Agreement for EGRIFTA(TM) in Latin America, Africa and the Middle East With Sanofi-Aventis (France) (SASY.PA) 12/6/2010 10:19:40 AM
Notice of Conference Call & Media Advisory: Theratechnologies Inc. (TH.TO) Announces a Partnership Agreement 12/6/2010 9:05:10 AM
Theratechnologies Inc. (TH.TO) Plans Early Adoption of International Financial Reporting Standards 12/2/2010 11:42:42 AM
12345678910...
//-->